GMP Violations At GSK's Former Puerto Rico Plant Are Basis Of $750 Million DoJ Settlement
This article was originally published in The Pink Sheet Daily
Executive Summary
In the first False Claims Act case alleging cGMP violations the government cites microbial contamination, split tablets and product mix-ups.